If it is Pseudomonas aeruginosa which i assume it is given Roche & Genetech have a lot of interest there with 3 ? maybe 4 ? deals over the last couple of years it's PYC's 3rd shot at it so would have a bit of data it was the focus of the $100m Astrazeneca / Mediimune deal a few years ago & they let Cubist look over it after that ?
PYC Price at posting:
1.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)